KaydedilenlerDerginizi ekleyin

Dergiler / Haseki Tıp Bülteni / 2021 / Cilt: 59 - Sayı: 5

Diagnostic Value of Novel Presepsin and Inflammatory Biomarkers in Predicting the Clinical Course of COVID-19

Faraz Hassan MİRZA
Faraz Ahmed BAİG
Serajuddaula SYED
Sayfa
358–362
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: We have determined that presepsin is the most sensitive prognostic indicator (93.3%) with a strong statistical association (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: The diagnostic value of inflammatory markers to determine the severity of Coronavirus disease-2019 (COVID-19) is postulated in some recent studies, but conclusions were inconsistent.
📊
Temel Bulgular & Veri:Hence, we intend to examine the utility of presepsin, procalcitonin and C-reactive protein in predicting the severity of COVID-19 infection.
💡
Sonuç & Katkı:Results: We have determined that presepsin is the most sensitive prognostic indicator (93.3%) with a strong statistical association (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: The diagnostic value of inflammatory markers to determine the severity of Coronavirus disease-2019 (COVID-19) is postulated in some recent studies, but conclusions were inconsistent. Hence, we intend to examine the utility of presepsin, procalcitonin and C-reactive protein in predicting the severity of COVID-19 infection. Methods: Single-center cross-sectional study was undertaken at the Intensive care unit of a university hospital. Eighty consecutive cases diagnosed with Severe Acute Respiratory syndrome-Coronavirus-2 RNA between October 2020 and July 2021 were classified according to the severity of the disease. Laboratory data related to Procalcitonin and C-reactive protein was retrieved from investigations coinciding with the day of admission. The stored plasma was subjected to an enzyme-linked immunosorbent assay to determine plasma presepsin levels. Statistical test for measures of screening was employed and a receiver operator curve was generated. Results: We have determined that presepsin is the most sensitive prognostic indicator (93.3%) with a strong statistical association (p

🔖

Bu Makaleye Atıf Yap

MİRZA, F. H., BAİG, F. A., SYED, S. (2022). Diagnostic Value of Novel Presepsin and Inflammatory Biomarkers in Predicting the Clinical Course of COVID-19. Haseki Tıp Bülteni, Cilt: 59 - Sayı: 5, 358–362. https://ajindex.com/articles/535135

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Organization WH. COVID-19 weekly epidemiological update, edition 45, 22 June 2021. 2021
  2. Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19), 2020
  3. Zaninotto M, Mion MM, Cosma C, Rinaldi D, Plebani M. Presepsin in risk stratification of SARS-CoV-2 patients. Clin Chim Acta 2020;507:161-3
  4. Bohn MK, Lippi G, Horvath A, et al. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med 2020;58:1037-52. doi: 10.1515/cclm-2020-0722. PMID: 32459192
  5. Afzal AJJoar. Molecular diagnostic technologies for COVID-19: Limitations and challenges. 2020
  6. Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. J Clin Microbiol 2020;58:e00512-20 7. Bennouar S, Bachir Cherif A, Kessira A, et al. Usefulness of biological markers in the early prediction of corona virus disease-2019 severity. Scand J Clin Lab Invest 2020;80:611-8
  7. Lippi G, Sanchis-Gomar F, Henry BM. Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis. Clin Chem Lab Med 2021
  8. Iwen PC, Stiles KL, Pentella MA. Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Am J Clin Pathol 2020:15;153:567-70
  9. Fukada A, Kitagawa Y, Matsuoka M, et al. Presepsin as a predictive biomarker of severity in COVID-19: A case series. J Med Virol 2021;93:99-101
  10. Domi H, Matsuura H, Kuroda M, Yoshida M, Yamamura H. Simple prognostic factors and change of inflammatory markers in patients with severe coronavirus disease 2019: a single-center observational study. Acute Med Surg 2021:12;8:683
  11. Ducastel M, Chenevier-Gobeaux C, Ballaa Y, et al. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19. Int J Mol Sci 2021:12;22:7462
  12. Hayashida K, Kondo Y, Hara Y, Aihara M, Yamakawa K. Headto-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis. BMJ Open 2017:6;7:014305
  13. Sankar V, Webster NRJJoa Clinical application of sepsis biomarkers. J Anesth 2013:;27:269-83
  14. Gasteiger S, Primavesi F, Werkl P, et al. The prognostic v